Potential public health effects of reducing nicotine levels in cigarettes in the United States

New England Journal of Medicine

Volumn 378, Issue 18, 2018, Pages 1725-1733

  Apelberg, Benjamin J ^a   Feirman, Shari P ^a   Salazar, Esther ^a   Corey, Catherine G ^a   Ambrose, Bridget K ^a   Paredes, Antonio ^a   Richman, Elise ^a   Verzi, Stephen J ^b   Vugrin, Eric D ^b   Brodsky, Nancy S ^b   Rostron, Brian L ^a  

^a CENTER FOR TOBACCO PRODUCTS   (United States)

^b SANDIA NATIONAL LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ARTICLE; BIRTH; CIGARETTE; CONCENTRATION (PARAMETERS); HEALTH CARE POLICY; MORTALITY; POPULATION MIGRATION; PRIORITY JOURNAL; PUBLIC HEALTH; SIMULATION; SMOKING REGULATION; TOBACCO USE; UNITED STATES; ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; EPIDEMIOLOGY; FEMALE; GOVERNMENT REGULATION; HUMAN; LEGISLATION AND JURISPRUDENCE; MALE; PREVALENCE; SEX RATIO; SMOKING; SMOKING PREVENTION; STANDARDS; TOBACCO; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; FEMALE; GOVERNMENT REGULATION; HEALTH POLICY; HUMANS; MALE; NICOTINE; PREVALENCE; SEX DISTRIBUTION; SMOKING; SMOKING PREVENTION; TOBACCO PRODUCTS; TOBACCO USE DISORDER; UNITED STATES;

EID: 85045400023     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsr1714617     Document Type: Article

References (48)

1. Institute of Medicine. Ending the tobacco problem: a blueprint for the nation. Washington, DC: National Academies Press, 2007 (https://www.nap.edu/catalog/11795/ending-the-tobacco-problem-a-blueprint-for-the-nation).
2. Benowitz NL. Nicotine addiction. N Engl J Med 2010;362: 2295-303.
3. Henningfield JE, Benowitz NL, Slade J, Houston TP, Davis RM, Deitchman SD. Reducing the addictiveness of cigarettes. Tob Control 1998;7:281-93.
4. Department of Health and Human Services. The health consequences of smoking - 50 years of progress: a report of the Surgeon General. Washington, DC: Government Printing Office, 2014.
5. Results from the 2013 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014 (http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf).
6. Department of Health and Human Services. Preventing tobacco use among youth and young adults - a report of the Surgeon General. Washington, DC: Government Printing Office, 2012.
7. Breslau N, Fenn N, Peterson EL. Early smoking initiation and nicotine dependence in a cohort of young adults. Drug Alcohol Depend 1993;33:129-37.
8. Chen J, Millar WJ. Age of smoking initiation: implications for quitting. Health Rep 1998;9(4):39-46.
9. Taioli E, Wynder EL. Effect of the age at which smoking begins on frequency of smoking in adulthood. N Engl J Med 1991; 325:968-9.
10. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease - a report of the Surgeon General. Washington, DC: Government Printing Office, 2010.
11. FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death. Silver Spring, MD: Food and Drug Administration, July 28, 2017 (https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm568923.htm).
12. Gottlieb S, Zeller M. A nicotine-focused framework for public health. N Engl J Med 2017;377:1111-4.
13. U.S. Congress. Federal Food Drug and Cosmetic Act Sec 907, 910, 911 - as amended by FSPTCA. 6-22-2009.
14. Levy DT, Chaloupka F, Gitchell J, Mendez D, Warner KE. The use of simulation models for the surveillance, justification and understanding of tobacco control policies. Health Care Manag Sci 2002;5:113-20.
15. Vugrin ED, Rostron BL, Verzi SJ, et al. Modeling the potential effects of new tobacco products and policies: a dynamic population model for multiple product use and harm. PLoS One 2015;10(3):e0121008.
16. Annual estimates of the resident population by single year of age and sex for the United States: April 1, 2010 to July 1, 2016. Washington, DC: Census Bureau, April 20, 2017 (https://www.census.gov/newsroom/press-releases/2017/cb17-tps38-population -estimates-single-year-age.html).
17. Selected characteristics of the native and foreign-born populations: 2011-2015 American Community Survey 5-year estimates. Washington, DC: Census Bureau (https://factfinder.census.gov/bkmk/table/1.0/en/ACS/15_5YR/S0501).
18. National Health Interview Survey home page (https://www.cdc.gov/nchs/nhis/data-questionnaires-documentation.htm).
19. National Youth Tobacco Survey (NYTS) home page (https://www.cdc.gov/tobacco/data_statistics/surveys/nyts/index.htm).
20. U.S. Census Bureau, 2014 National Population Projection Data-sets (https://www.census.gov/data/datasets/2014/demo/popproj/2014-popproj.html).
21. Hyndman R, Koehler AB, Ord JK, Snyder RD. Forecasting with exponential smoothing: the state space approach. New York: Springer Science & Business Media, 2008.
22. Hyndman RJ, Khandakar Y. Automatic time series for forecasting: the forecast package for R. Clayton, VIC, Australia: Monash University, Department of Econometrics and Business Statistics, 2007.
23. Preston S, Heuveline P, Guillot M. Demography: measuring and modeling population processes. New York: Wiley, 2001.
24. Lee R, Carter L. Modeling and forecasting US mortality. J Am Stat Assoc 1992;87:659-71.
25. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519.
26. Enstrom JE, Heath CW Jr. Smoking cessation and mortality trends among 118,000 Californians, 1960-1997. Epidemiology 1999;10:500-12.
27. Henley SJ, Thun MJ, Connell C, Calle EE. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 2005;16:347-58.
28. Henley SJ, Connell CJ, Richter P, et al. Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco. Tob Control 2007;16:22-8.
29. Tam J, Levy DT, Jeon J, et al. A study protocol for projecting the effects of tobacco control policies in the United States through microsimulation. BMJ Open (in press).
30. Becker KM, Rose JE, Albino AP. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Nicotine Tob Res 2008;10: 1139-48.
31. Benowitz NL, Dains KM, Hall SM, et al. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev 2012;21:761-9.
32. Dermody SS, Donny EC, Hertsgaard LA, Hatsukami DK. Greater reductions in nicotine exposure while smoking very low nicotine content cigarettes predict smoking cessation. Tob Control 2015;24:536-9.
33. Donny EC, Denlinger RL, Tidey JW, et al. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med 2015; 373:1340-9.
34. McRobbie H, Przulj D, Smith KM, Cornwall D. Complementing the standard multicomponent treatment for smokers with denicotinized cigarettes: a randomized trial. Nicotine Tob Res 2016;18:1134-41.
35. Walker N, Fraser T, Howe C, et al. Abrupt nicotine reduction as an endgame policy: a randomised trial. Tob Control 2015; 24(e4):e251-e257.
36. Walker N, Howe C, Bullen C, et al. The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial. Addiction 2012;107:1857-67.
37. Benowitz NL, Nardone N, Dains KM, et al. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up. Addiction 2015;110:1667-75.
38. Donny EC, Jones M. Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine. Drug Alcohol Depend 2009;104:23-33.
39. Hatsukami DK, Donny EC, Koopmeiners JS, Benowitz NL. Compensatory smoking from gradual and immediate reduction in cigarette nicotine content. Cancer Epidemiol Biomarkers Prev 2015;24:472-6.
40. Hatsukami DK, Kotlyar M, Hertsgaard LA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction 2010;105:343-55.
41. Hatsukami DK, Luo X, Dick L, et al. Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial. Addiction 2017;112:156-67.
42. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology (Berl) 1999;145:1-20.
43. Benowitz NL, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P III. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomarkers Prev 2007;16:2479-85.
44. Ding YS, Ward J, Hammond D, Watson CH. Mouth-level intake of benzo[a]pyrene from reduced nicotine cigarettes. Int J Environ Res Public Health 2014;11:11898-914.
45. Tidey JW, Pacek LR, Koopmeiners JS, et al. Effects of 6-week use of reduced-nicotine content cigarettes in smokers with and without elevated depressive symptoms. Nicotine Tob Res 2017; 19:59-67.
46. National Research Council. Understanding the U.S. illicit tobacco market: characteristics, policy context, and lessons from international experiences. Washington, DC: National Academies Press, 2015.
47. Tengs TO, Ahmad S, Savage JM, Moore R, Gage E. The AMA proposal to mandate nicotine reduction in cigarettes: a simulation of the population health impacts. Prev Med 2005;40:170-80.
48. Hatsukami DK, Perkins KA, Lesage MG, et al. Nicotine reduction revisited: science and future directions. Tob Control 2010;19(5):e1-e10.